Recombinant KRT20 anticorps (AA 196-323)

N° du produit ABIN7871714

Cet anticorps Lapin Monoclonal détecte spécifiquement KRT20 dans WB et IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Recombinant KRT20 anticorps (AA 196-323) (ABIN7871714)

Antigène: KRT20 (Keratin 20 (KRT20))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp KRT20 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: KRT20-3129R

Détail du produit anti-KRT20 anticorps

Épitope: AA 196-323

Fonction: Recombinant CK20 Antibody / Cytokeratin 20 (azide and preservative free)

Purification: Protein A affinity chromatography

Immunogène: A recombinant human partial protein (amino acids 196-323) was used as the immunogen for this Cytokeratin 20 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the recombinant CK20 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the recombinant CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur KRT20

Antigène: KRT20 (Keratin 20 (KRT20))

Autre désignation: CK20

Sujet: This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900